These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 27895192)

  • 1. Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients: The Campania Salute Network.
    Izzo R; Losi MA; Stabile E; Lönnebakken MT; Canciello G; Esposito G; Barbato E; De Luca N; Trimarco B; de Simone G
    Hypertension; 2017 Jan; 69(1):136-142. PubMed ID: 27895192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network).
    Lønnebakken MT; Izzo R; Mancusi C; Gerdts E; Losi MA; Canciello G; Giugliano G; De Luca N; Trimarco B; de Simone G
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28275070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network).
    Gerdts E; Izzo R; Mancusi C; Losi MA; Manzi MV; Canciello G; De Luca N; Trimarco B; de Simone G
    Int J Cardiol; 2018 May; 258():257-261. PubMed ID: 29544940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study.
    Devereux RB; Palmieri V; Liu JE; Wachtell K; Bella JN; Boman K; Gerdts E; Nieminen MS; Papademetriou V; Dahlöf B
    J Hypertens; 2002 Jul; 20(7):1445-50. PubMed ID: 12131543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.
    Pierdomenico SD; Lapenna D; Cuccurullo F
    Am J Hypertens; 2008 Apr; 21(4):464-70. PubMed ID: 18369364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight loss facilitates reduction of left ventricular mass in obese hypertensive patients: The Campania Salute Network.
    Lønnebakken MT; Mancusi C; Losi MA; Gerdts E; Izzo R; Manzi MV; De Luca N; de Simone G; Trimarco B
    Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):185-190. PubMed ID: 30559043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
    Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
    Gerdts E; Okin PM; Boman K; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
    Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Normal Blood Pressure and Left Ventricular Hypertrophy Echocardiographic Findings From the PAMELA Population.
    Cuspidi C; Facchetti R; Bombelli M; Tadic M; Sala C; Grassi G; Mancia G
    Hypertension; 2019 Mar; 73(3):612-619. PubMed ID: 30612493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of left ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new heart failure.
    Okin PM; Wachtell K; Gerdts E; Dahlöf B; Devereux RB
    J Hypertens; 2014 Dec; 32(12):2472-8; discussion 2478. PubMed ID: 25340854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aortic Root Dilatation Is Associated With Incident Cardiovascular Events in a Population of Treated Hypertensive Patients: The Campania Salute Network.
    Canciello G; Mancusi C; Losi MA; Izzo R; Trimarco B; de Simone G; De Luca N
    Am J Hypertens; 2018 Nov; 31(12):1317-1323. PubMed ID: 30099532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressed myocardial energetic efficiency is associated with increased cardiovascular risk in hypertensive left ventricular hypertrophy.
    de Simone G; Izzo R; Losi MA; Stabile E; Rozza F; Canciello G; Mancusi C; Trimarco V; De Luca N; Trimarco B
    J Hypertens; 2016 Sep; 34(9):1846-53. PubMed ID: 27367264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of blood pressure control on prevalence of left ventricular hypertrophy in treated hypertensive patients.
    Cuspidi C; Lonati L; Sampieri L; Macca G; Michev I; Salerno M; Fusi V; Leonetti G; Zanchetti A
    Cardiology; 2000; 93(3):149-54. PubMed ID: 10965085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
    Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
    Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
    Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
    Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects.
    Verdecchia P; Angeli F; Gattobigio R; Sardone M; Pede S; Reboldi GP
    Am J Hypertens; 2006 May; 19(5):493-9. PubMed ID: 16647622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of obesity on prevalence of cardiac and carotid target organ damage in hypertension (the Campania Salute Network).
    Mancusi C; Gerdts E; Losi MA; D'Amato A; Manzi MV; Canciello G; Trimarco V; De Luca N; de Simone G; Izzo R
    Int J Cardiol; 2017 Oct; 244():260-264. PubMed ID: 28629621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining ECG Criteria for Left Ventricular Hypertrophy Improves Risk Prediction in Patients With Hypertension.
    Okin PM; Hille DA; Kjeldsen SE; Devereux RB
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29151037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
    Ketelhut S; Franz IW; Ketelhut RG
    High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.